(Q50505361)

14 March 2018

title

Effect of pioglitazone on transdifferentiation of preosteoblasts from rat bone mesenchymal stem cells into adipocytes. (English)

1 reference

14 March 2018

1 reference

mesenchymal stem cell

1 reference

Linfang Wang

1

1 reference

14 March 2018

Lihua Li

series ordinal

2

1 reference

14 March 2018

Haibo Gao

series ordinal

3

1 reference

14 March 2018

Yuming Li

series ordinal

4

1 reference

14 March 2018

publication date

11 August 2012

1 reference

14 March 2018

Journal of Huazhong University of Science and Technology [Medical Sciences]

published in

1 reference

14 March 2018

volume

32

1 reference

14 March 2018

issue

4

1 reference

14 March 2018

page(s)

530-533

1 reference

14 March 2018

Thiazolidinedione use and bone loss in older diabetic adults

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0091-X

Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0091-X

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0091-X

Bone is a target for the antidiabetic compound rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0091-X

Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0091-X

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0091-X

Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0091-X

Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells

21 January 2018

1 reference

12 December 2020

Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men

1 reference

12 December 2020

Clinical translation of "a diabetes outcome progression trial": ADOPT appropriate combination oral therapies in type 2 diabetes

1 reference

12 December 2020

PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats

1 reference

12 December 2020

10.1007/S11596-012-0091-X

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

22886965

1 reference

14 March 2018